Public Profile

Longeveron Inc.

Longeveron Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative cell therapies to address age-related and degenerative diseases. Founded in 2014, Longeveron has made significant strides in the field of regenerative medicine, particularly with its unique product offerings centred around mesenchymal stem cells (MSCs). The company’s flagship therapies aim to enhance healthspan and improve quality of life for patients suffering from conditions such as frailty and heart disease. Longeveron has established a strong market position, recognised for its commitment to scientific excellence and patient-centric solutions. With ongoing clinical trials and collaborations, Longeveron continues to lead the way in advancing the future of cellular therapies.

DitchCarbon Score

How does Longeveron Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Longeveron Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Longeveron Inc.'s reported carbon emissions

Longeveron Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. Without specific targets or initiatives outlined, it is unclear how Longeveron Inc. plans to address its carbon footprint or contribute to climate action within its industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Longeveron Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Longeveron Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Longeveron Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

TEI Biosciences Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 month ago
DitchCarbon Score

Osiris Therapeutics, Inc.

US
Health and social work services (85)
Updated about 1 month ago
DitchCarbon Score

American CryoStem Corporation

US
Health and social work services (85)
Updated 14 days ago

Smart Surgical, Inc.

US
Health and social work services (85)
Updated 21 days ago

Compugen Ltd.

IL
Health and social work services (85)
Updated 14 days ago

Liveyon LLC.

US
Research and development services (73)
Updated 17 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers